DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair - PubMed (original) (raw)
DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair
J T Drummond et al. Proc Natl Acad Sci U S A. 1997.
Abstract
The level and fate of hMSH3 (human MutS homolog 3) were examined in the promyelocytic leukemia cell line HL-60 and its methotrexate-resistant derivative HL-60R, which is drug resistant by virtue of an amplification event that spans the dihydrofolate reductase (DHFR) and MSH3 genes. Nuclear extracts from HL-60 and HL-60R cells were subjected to an identical, rapid purification protocol that efficiently captures heterodimeric hMutSalpha (hMSH2. hMSH6) and hMutSbeta (hMSH2.hMSH3). In HL-60 extracts the hMutSalpha to hMutSbeta ratio is roughly 6:1, whereas in methotrexate-resistant HL-60R cells the ratio is less than 1:100, due to overproduction of hMSH3 and heterodimer formation of this protein with virtually all the nuclear hMSH2. This shift is associated with marked reduction in the efficiency of base-base mismatch and hypermutability at the hypoxanthine phosphoribosyltransferase (HPRT) locus. Purified hMutSalpha and hMutSbeta display partial overlap in mismatch repair specificity: both participate in repair of a dinucleotide insertion-deletion heterology, but only hMutSalpha restores base-base mismatch repair to extracts of HL-60R cells or hMSH2-deficient LoVo colorectal tumor cells.
Figures
Figure 1
Organization of human MutS homolog genes. The MSH3 gene is divergently transcribed from a promoter region shared with the DHFR gene (11, 41). The DHFR copy number (n) is about 200 in Mtxr HL-60R cells (11). Genes encoding the two polypeptides that comprise hMutSα, MSH2 and MSH6, reside in close proximity on chromosome 2 (20, 33). The relative orientation of transcription shown for MSH2 and MSH6 is arbitrary.
Figure 2
Western analysis of MutS homologs. (A) In each of the first four lanes, 75 μg of the indicated nuclear extract was loaded and probed independently for hMSH2, hMSH3, or hMSH6. In the latter four lanes, the indicated amount (ng) of purified hMutSα or hMutSβ was loaded to demonstrate the lower detection limits of the experiment. (B) The efficiency of retention of hMSH2 on single-stranded DNA cellulose is shown for extracts derived from HL-60 and HL-60R cells. The volume loaded was normalized in each case to that of the extract sample. In the two right lanes, purified hMutSα (100 ng) was subjected to electrophoresis in the presence or absence of LoVo extract (50 μg) to demonstrate the effect of high protein concentration on electrophoretic mobility and blotting efficiency.
Figure 3
Resolution of hMutSα and hMutSβ on MonoQ. MonoQ anion exchange FPLC chromatography was performed on DNA cellulose eluates (see Materials and Methods) prepared from HL-60 extract (Upper) or HL-60R extract (Lower). In each case, the upper section shows results of a Coomassie-stained gel, and the middle section shows the corresponding Western blot for the hMSH2, hMSH3, and hMSH6 polypeptides. The positions of subunit polypeptides of hMutSα and hMutSβ in stained gels are indicated by arrows. Each fraction (2.5 μl of 500 μL) was tested for its ability to complement repair-deficient LoVo extract on a 3′ /CA/ insertion–deletion heteroduplex.
Figure 4
Complementation activity of hMutSα and hMutSβ. Circular heteroduplexes containing a G-T base–base mismatch (Upper) or a /CA/ insertion–deletion mispair (Lower) were used to determine extract repair activities in the absence of exogenous proteins (empty bars), in the presence of added hMutSα (hatched bars), or hMutSβ (filled bars). Error bars are ± 1 SD. The G-T substrate had a strand break at the _Sau_96I site located 181 nucleotides 5′ to the mismatch (shorter path in the circular substrate), whereas the /CA/ heteroduplex had a strand break 125 nucleotides 3′ to mispair (23, 42).
Similar articles
- Mismatch repair deficiency associated with overexpression of the MSH3 gene.
Marra G, Iaccarino I, Lettieri T, Roscilli G, Delmastro P, Jiricny J. Marra G, et al. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8568-73. doi: 10.1073/pnas.95.15.8568. Proc Natl Acad Sci U S A. 1998. PMID: 9671718 Free PMC article. - Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.
Genschel J, Littman SJ, Drummond JT, Modrich P. Genschel J, et al. J Biol Chem. 1998 Jul 31;273(31):19895-901. doi: 10.1074/jbc.273.31.19895. J Biol Chem. 1998. PMID: 9677427 - Functional overlap in mismatch repair by human MSH3 and MSH6.
Umar A, Risinger JI, Glaab WE, Tindall KR, Barrett JC, Kunkel TA. Umar A, et al. Genetics. 1998 Apr;148(4):1637-46. doi: 10.1093/genetics/148.4.1637. Genetics. 1998. PMID: 9560383 Free PMC article. - Genomic amplification of the human DHFR/MSH3 locus remodels mismatch recognition and repair activities.
Drummond JT. Drummond JT. Adv Enzyme Regul. 1999;39:129-41. doi: 10.1016/s0065-2571(98)00013-2. Adv Enzyme Regul. 1999. PMID: 10470370 Review. - Molecular mechanisms of resistance to antifolates, a review.
Banerjee D, Ercikan-Abali E, Waltham M, Schnieders B, Hochhauser D, Li WW, Fan J, Gorlick R, Goker E, Bertino JR. Banerjee D, et al. Acta Biochim Pol. 1995;42(4):457-64. Acta Biochim Pol. 1995. PMID: 8852336 Review.
Cited by
- In search of the pH limit of growth in halo-alkaliphilic cyanobacteria.
Yi L, Solanki R, Strous M. Yi L, et al. Environ Microbiol Rep. 2024 Aug;16(4):e13323. doi: 10.1111/1758-2229.13323. Environ Microbiol Rep. 2024. PMID: 39128846 Free PMC article. - Dynamic genomic changes in methotrexate-resistant human cancer cell lines beyond DHFR amplification suggest potential new targets for preventing drug resistance.
Meng XN, Ma JF, Liu YH, Li SQ, Wang X, Zhu J, Cai MD, Zhang HS, Song T, Xing S, Hou LQ, Guo H, Cui XB, Han J, Liu P, Ji GH, Sun WJ, Yu JC, Fu SB. Meng XN, et al. Br J Cancer. 2024 May;130(11):1819-1827. doi: 10.1038/s41416-024-02664-0. Epub 2024 Apr 9. Br J Cancer. 2024. PMID: 38594370 Free PMC article. - Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines.
Casotti C, Hattinger CM, Patrizio MP, Luppi S, Fantoni L, Pasello M, Scotlandi K, Ibrahim T, Serra M. Casotti C, et al. Front Pharmacol. 2023 Nov 22;14:1294873. doi: 10.3389/fphar.2023.1294873. eCollection 2023. Front Pharmacol. 2023. PMID: 38074116 Free PMC article. - Elevated MSH2 MSH3 expression interferes with DNA metabolism in vivo.
Medina-Rivera M, Phelps S, Sridharan M, Becker J, Lamb NA, Kumar C, Sutton MD, Bielinsky A, Balakrishnan L, Surtees JA. Medina-Rivera M, et al. Nucleic Acids Res. 2023 Dec 11;51(22):12185-12206. doi: 10.1093/nar/gkad934. Nucleic Acids Res. 2023. PMID: 37930834 Free PMC article. - HTLV-1 bZIP factor impairs DNA mismatch repair system.
Sakurada-Aono M, Sakamoto T, Kobayashi M, Takiuchi Y, Iwai F, Tada K, Sasanuma H, Hirabayashi S, Murakawa Y, Shirakawa K, Sakamoto C, Shindo K, Yasunaga JI, Matsuoka M, Pommier Y, Takeda S, Takaori-Kondo A. Sakurada-Aono M, et al. Biochem Biophys Res Commun. 2023 May 21;657:43-49. doi: 10.1016/j.bbrc.2023.03.049. Epub 2023 Mar 21. Biochem Biophys Res Commun. 2023. PMID: 36972660 Free PMC article.
References
- Huennekens F M. Adv Enzyme Regul. 1994;34:397–419. - PubMed
- Bertino J R. J Clin Oncol. 1993;11:5–15. - PubMed
- Osborn M J, Freeman M, Huennekens F M. Proc Soc Exp Biol Med. 1958;97:429–431. - PubMed
- Blakley R L. In: Folates and Pterins. Blakley R L, Benkovic S J, editors. Vol. 1. New York: Wiley; 1984. pp. 191–253.
- Carman M D, Schomagel J H, Rivest R S, Srimatkandada S, Portlock C S, Duffy T, Bertino J R. J Clin Oncol. 1984;2:16–20. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous